The FDA is right to be angry that 23andMe doesn’t appear to be taking the regulatory process seriously. There are cases of 23andMe interpreting results in misleading ways, and geneticists have been worried that people may not realise that the results it provides only give a part of the picture. There is also good reason to be sceptical of any company that wants to suck up genetic information and monetise it just as thoroughly as Google has done with digital information.
Yet, I ordered a kit. Why? Because I couldn’t resist even the slight glimpse of me that it offers.
Read the full, original story: Home genome testing is coming, and regulators need to make sure they’re ready